Informational and Supportive Care for Rectal Cancer (PATHWAYS)
This study is testing an informational and supportive care program called PATHWAYS for people with locally advanced rectal cancer (LARC). PATHWAYS involves four coaching sessions and a patient education guidebook. It's being compared to an "enhanced usual care" group, which receives an information resource guide. The main goal is to see if it's practical and acceptable to conduct a larger study on PATHWAYS. You might be able to join if you are at least 18 years old, have newly diagnosed LARC (stage II or III), and are starting multi-modality treatment (like chemotherapy and radiation). About 80 people are expected to participate in this study.
- Study design
- This is a randomized controlled trial, meaning participants are randomly assigned to either the PATHWAYS intervention or enhanced usual care. It is a pilot study, with about 80 participants planned.
- What's involved
- Participants in the PATHWAYS group will have 4 coaching sessions. The study will measure how many participants stay in the intervention for 4 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint for feasibility is measured at 4 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Kelsey Lau-Min, MD, MSCE · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Proportion of participants retained in the intervention (feasibility)4 weeks
The primary outcome will be feasibility, defined as ≥60% retention of participants over the four-week intervention.